Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Ican interview/https://youtu.be/kUnXQXXKVUU
Ananda holds 15% of the equity in LHT and one board seat. Further to the update of 30 October 2020, LHT continues to explore and assess other opportunities for its vaping product.
In particular, LHT is assessing the opportunity to have its inhaler certified for use as a medical device. This would open up opportunities in this growing sector, where the vaping of cannabis flower is the preferred dosage mechanism. LHT’s ability to deliver a measured dose of medicinal cannabis flower is an attractive, non-carcinogenic route to delivering high bio-availability medical cannabis benefits to patients.
– It holds an investment in iCAN Israel Cannabis, one of the leading global cannabis conference companies and also an incubator of companies in the cannabis sector. Ananda uses its relationship with iCAN to source intellectual capital and remain up to date with developments in medicinal cannabis research
– It holds 15% of Liberty Herbal Technologies, the 100% owner of hapac, a system for the inhalation of medicinal cannabis. Ananda sees the opportunity for hapac to be used in the medicinal cannabis sector in the UK in the future and potentially in other markets in the near term.
Love it not many shares in free float Name Number of Ordinary Shares % of Issued Share Capital
URA Holdings Plc 88,888,888 15.22
Barnard Nominees Limited 83,592,058 14.31
Lynchwood Nominees Limited 52,000,000 8.90
Charles Morgan 45,541,666 7.80
Melissa Sturgess 45,541,666 7.80
Jim Nominees Limited 35,969,076 6.16
Redmayne Nominees Limited 34,888,889 5.97
Pershing Securities Limited 30,000,000 5.14
Hargreaves Lansdown Nominees Limited 29,675,639 5.08
Redmayne Nominees Limited 22,222,223